Cite
HARVARD Citation
Reau, N. et al. (n.d.). High SVR Rates Among US Patients Regardless of Race or Ethnicity in HCV GT1 Patients Receiving the Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r+Dasabuvir±Ribavirin: Integrated Safety and Efficacy Analysis. American journal of gastroenterology. p. . [Online].